000 02465 a2200745 4500
005 20250516204033.0
264 0 _c20140609
008 201406s 0 0 eng d
022 _a1527-3350
024 7 _a10.1002/hep.26898
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFuchs, Bryan C
245 0 0 _aEpidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cApr 2014
300 _a1577-90 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBile Ducts
_xphysiopathology
650 0 4 _aCarbon Tetrachloride
_xadverse effects
650 0 4 _aCarcinoma, Hepatocellular
_xpathology
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDiethylnitrosamine
_xadverse effects
650 0 4 _aDisease Models, Animal
650 0 4 _aDisease Progression
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aHepatic Stellate Cells
_xdrug effects
650 0 4 _aHepatocytes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLigation
_xadverse effects
650 0 4 _aLiver Cirrhosis
_xetiology
650 0 4 _aLiver Neoplasms
_xpathology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPrognosis
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aTranscriptome
700 1 _aHoshida, Yujin
700 1 _aFujii, Tsutomu
700 1 _aWei, Lan
700 1 _aYamada, Suguru
700 1 _aLauwers, Gregory Y
700 1 _aMcGinn, Christopher M
700 1 _aDePeralta, Danielle K
700 1 _aChen, Xintong
700 1 _aKuroda, Toshihiko
700 1 _aLanuti, Michael
700 1 _aSchmitt, Anthony D
700 1 _aGupta, Supriya
700 1 _aCrenshaw, Andrew
700 1 _aOnofrio, Robert
700 1 _aTaylor, Bradley
700 1 _aWinckler, Wendy
700 1 _aBardeesy, Nabeel
700 1 _aCaravan, Peter
700 1 _aGolub, Todd R
700 1 _aTanabe, Kenneth K
773 0 _tHepatology (Baltimore, Md.)
_gvol. 59
_gno. 4
_gp. 1577-90
856 4 0 _uhttps://doi.org/10.1002/hep.26898
_zAvailable from publisher's website
999 _c23684569
_d23684569